Your browser doesn't support javascript.
loading
Exploratory phase 2 study of the novel oral multi-kinase inhibitor TAS-115 in patients with idiopathic pulmonary fibrosis.
Nishioka, Yasuhiko; Homma, Sakae; Ogura, Takashi; Sato, Seidai; Arai, Naoki; Tomii, Keisuke; Kamio, Koichiro; Sakamoto, Susumu; Miyazaki, Yasunari; Tomioka, Hiromi; Hisata, Shu; Handa, Tomohiro; Azuma, Arata.
Afiliación
  • Nishioka Y; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan; 3-18-15, Kuramoto-cho, Tokushima, 770-8503, Japan. Electronic address: yasuhiko@tokushima-u.ac.jp.
  • Homma S; Department of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan; 6-11-1 Omorinishi, Ota-ku, Tokyo, 143-8540, Japan.
  • Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan; 6-16-1 Tomiokahigashi, Kanazawa-ku, Yokohama, Kanagawa, 236-0051, Japan.
  • Sato S; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan; 3-18-15, Kuramoto-cho, Tokushima, 770-8503, Japan.
  • Arai N; Department of Respiratory Medicine, National Hospital Organization, Ibaraki Higashi National Hospital, Ibaraki, Japan; 825 Terunuma, Tokaimura, Naka-gun, Ibaraki, 319-1113, Japan.
  • Tomii K; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan; 2-1-1, Minatojimaminamimachi, Chuo-ku, Kobe-city, Hyogo, 650-0047, Japan.
  • Kamio K; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School Tokyo, Japan; 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.
  • Sakamoto S; Department of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan; 6-11-1 Omorinishi, Ota-ku, Tokyo, 143-8540, Japan.
  • Miyazaki Y; Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan; 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
  • Tomioka H; Department of Respiratory Medicine, Kobe City Medical Center West Hospital, Kobe, Japan; 2-4, Ichiban-cho, Nagata-ku, Kobe-city, Hyogo, 653-0013, Japan.
  • Hisata S; Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan; 3311-1 Yakushiji, Shimotsuke-shi, Tochigi, 329-0498, Japan.
  • Handa T; Department of Advanced Medicine for Respiratory Failure/Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Azuma A; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School Tokyo, Japan; 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.
Respir Investig ; 61(4): 498-507, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37263115
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quinolinas / Fibrosis Pulmonar Idiopática Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Respir Investig Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quinolinas / Fibrosis Pulmonar Idiopática Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Respir Investig Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos